PAREXOL, created in 2013 (Czech Republic), from 2757 sister brands and 17478 competing brands. PAREXOL is owned by SANOFI, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. The sector of PAREXOL is Drug Manufacturers.